Next year promises “a rough road .for some sites” when it comes to budgeting and designing financial workflows to sustain operations, says Dr. Kelly Willenberg, DBA, RN, CCRP, CHC, CHRC, […]
Two Phase III clinical trials have begun evaluating investigational monoclonal antibodies for their safety and efficacy in treating people hospitalized with moderate COVID-19. The trials are part of the ACTIV-3 […]
The U.S. Food and Drug Administration (FDA) recently released a final guidance detailing the process for sponsors and clinical researchers to submit plans for new drug development tools (DDTs) for […]
PAID MESSAGE The COVID-19 pandemic is a challenge that is forcing us to reexamine how we do pretty much everything. There is no roadmap—just a barrage of mutable information. […]
Tomorrow’s clinical trials workforce will face demands and expectations almost unimaginable today. To thrive, the workforce is going to need a new level of training, greater diversity, and richer understanding […]